This is the authors' abstract. We don't add key points for this paper.
Nucleosides, due to their biological role as constituents of nucleic acids, are main targets in the development of analogues aimed at antimetabolite-based therapy. Modified nucleosides can disrupt ...
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ferraboschi et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: